Biopharma marketing outlook 2025
Healthcare professionals’ doors closed during the pandemic, and mostly they haven’t reopened. Meanwhile emerging technologies such as AI, digital integration, and modular platforms haven’t yet found mainstream adoption.
While this is causing headaches across the industry, it also presents huge opportunities for those who have the mindset and technology to grasp them.
In our new report, you’ll learn the key trends that are shaping biopharma marketing, including:
- How modular platforms will bridge biopharma’s digital disconnect across commercial execution
- The impact of direct-to-stakeholder approaches in improving HCP and patient experiences
- The role of AI in delivering fast, personalized information and ensuring compliance on a global scale
Get it for free now to ensure you’re ready for whatever 2025 brings you and your team.
For years, pharma companies have invested heavily in technologies to help deliver the right message to the right channel. The same will happen with AI. It will take a couple of years and a few revelations. However, 2025 will be the year that we will see the most growth in terms of GenAI. It will create the base for everything
Siloed systems create the problem of siloed medicine.
.png){kind=logo}
One way to reduce technical debt is to take content management (CMS), digital asset management (DAM), customer data platform (CDP), and customer relationship management (CRM) systems and integrate them into a central digital experience platform (DXP). This will result in less maintenance and oversight.
We’ve been acting as problem solvers. From primary school to work environments, we are taught to solve problems. With AI, you are transforming from problem solver to problem explainer. The real shift is in the way we work.
Transcription and ambient listening will be a big AI trend this year. Ten times more data will be captured, but hospitals will keep all that data. If biopharma can collaborate with health systems to better understand the education needs of doctors, they can better serve them. This data represents an untapped opportunity.
Where time and accuracy are critical, healthcare professionals often turn to search engines for quick access to reliable information. However, physicians experience frustration, especially if they are looking for images or videos which may not have been indexed properly for search...they will see irrelevant results, and these inefficiencies can disrupt workflows and will ultimately hinder efforts to strengthen HCP-pharma relationships, where access to accurate resources is essential.
Rather than looking for information directly, their primary care provider will offer specifics related to each patient’s diagnosis and treatment plan.
SEO is thriving because pharma now understands the importance of being visible at the right time and in the right place.
A collaborative approach places an increased emphasis on analytics and engagement, ultimately leading to better, measurable outcomes.
